Anthony F Suffredini

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Novel therapies for septic shock over the past 4 decades
    Anthony F Suffredini
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bldg 10, Rm 2C145, Bethesda, MD 20892, USA
    JAMA 306:194-9. 2011
  2. ncbi Quality control of serum albumin depletion for proteomic analysis
    Nitin Seam
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892 1662, USA
    Clin Chem 53:1915-20. 2007
  3. ncbi Bundled care for septic shock: an analysis of clinical trials
    Amisha V Barochia
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    Crit Care Med 38:668-78. 2010
  4. ncbi Rapid induction of autoantibodies during ARDS and septic shock
    Peter D Burbelo
    Neurobiology and Pain Therapeutics Section, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Transl Med 8:97. 2010
  5. ncbi Proteomics
    Gerard T Hoehn
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    Crit Care Med 33:S444-8. 2005
  6. ncbi A canine model of septic shock: balancing animal welfare and scientific relevance
    Peter C Minneci
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892, USA
    Am J Physiol Heart Circ Physiol 293:H2487-500. 2007
  7. ncbi Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease
    Susan Yuditskaya
    Pulmonary and Vascular Medicine Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1476, USA
    Blood 113:1122-8. 2009
  8. ncbi Influence of IFN-gamma on gene expression in normal human bronchial epithelial cells: modulation of IFN-gamma effects by dexamethasone
    Rafal Pawliczak
    Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland 20892, USA
    Physiol Genomics 23:28-45. 2005
  9. ncbi Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage
    Carlos de Torre
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    Proteomics 6:3949-57. 2006

Collaborators

  • Peter Q Eichacker
  • Nitin Seam
  • Robert S Munford
  • Xizhong Cui
  • Gregory J Kato
  • Amisha V Barochia
  • Kathryn H Ching
  • Peter J Munson
  • Gerard T Hoehn
  • Peter D Burbelo
  • Susan Yuditskaya
  • G Umberto Meduri
  • Peter C Minneci
  • Sai-Xia Ying
  • Robert L Danner
  • Carlos de Torre
  • Rafal Pawliczak
  • Michael J Iadarola
  • Brian L Han
  • Sandra Groot
  • Amy H Chi
  • Alan T Remaley
  • Rong Fong Shen
  • Ashaunta Tumblin
  • Guanghui Wang
  • Xiuli Xu
  • Steven K Drake
  • Saixia Ying
  • Steven J Kern
  • Michael A Solomon
  • Sai Xia Ying
  • Peter Munson
  • Chris Romines
  • Katherine J Deans
  • Charles Natanson
  • Bernie Hansen
  • Steven M Banks
  • Chantal Parent
  • Denise A Gonzales
  • Jing Feng
  • Steven B Solomon
  • Carolea Logun
  • James H Shelhamer
  • Jennifer Barb
  • Patricia Madara

Detail Information

Publications9

  1. ncbi Novel therapies for septic shock over the past 4 decades
    Anthony F Suffredini
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bldg 10, Rm 2C145, Bethesda, MD 20892, USA
    JAMA 306:194-9. 2011
    ..In this Grand Rounds, we summarize the results of the clinical trials conducted during the last 4 decades, discuss some lessons learned, and suggest possible directions for future investigation...
  2. ncbi Quality control of serum albumin depletion for proteomic analysis
    Nitin Seam
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892 1662, USA
    Clin Chem 53:1915-20. 2007
    ..We examined the reproducibility of albumin immunodepletion and describe a method of QC for this process...
  3. ncbi Bundled care for septic shock: an analysis of clinical trials
    Amisha V Barochia
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    Crit Care Med 38:668-78. 2010
    ..Valid bundles require effective components with additive benefits. Proponents encourage evaluation of bundles, both as a whole and based on the performance of each component...
  4. ncbi Rapid induction of autoantibodies during ARDS and septic shock
    Peter D Burbelo
    Neurobiology and Pain Therapeutics Section, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Transl Med 8:97. 2010
    ....
  5. ncbi Proteomics
    Gerard T Hoehn
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    Crit Care Med 33:S444-8. 2005
  6. ncbi A canine model of septic shock: balancing animal welfare and scientific relevance
    Peter C Minneci
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892, USA
    Am J Physiol Heart Circ Physiol 293:H2487-500. 2007
    ..The integration into this model of both specific and supportive titrated therapies routinely used in septic patients may provide a more realistic setting to evaluate therapies for sepsis...
  7. ncbi Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease
    Susan Yuditskaya
    Pulmonary and Vascular Medicine Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892 1476, USA
    Blood 113:1122-8. 2009
    ..These results imply a relationship of apolipoproteins to the development of PAH vasculopathy in SCD, potentially involving an unexpected mechanistic parallel to atherosclerosis, another proliferative vasculopathy...
  8. ncbi Influence of IFN-gamma on gene expression in normal human bronchial epithelial cells: modulation of IFN-gamma effects by dexamethasone
    Rafal Pawliczak
    Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland 20892, USA
    Physiol Genomics 23:28-45. 2005
    ..Dex had little effect on the immediate early response to IFN-gamma but a significant effect on the late responses...
  9. ncbi Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage
    Carlos de Torre
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    Proteomics 6:3949-57. 2006
    ..This pattern was also found in ARDS BAL after immunoblot analysis. These approaches will be useful to improve current methods of monitoring lung inflammation and to identify new therapeutic targets...